Yüklüyor......
Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
Anti-PD-1/PD-L1 therapy has achieved great success in the clinic; however, only a small fraction of cancer patient benefit from PD-1/PD-L1 blockade therapy, and overcoming resistance to PD-1/PD-L1 blockade has thus become a primary priority. In this study, we demonstrated that administration of PD-1...
Kaydedildi:
| Yayımlandı: | Oncoimmunology |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5665063/ https://ncbi.nlm.nih.gov/pubmed/29123963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1349587 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|